An integrated approach to detection

For accurate detection of all types of genetic aberrations, various technologies are required. By combining information from multiple technologies, researchers can analyse complex samples and get the most complete overview of disease-driving mutations.

OGT offers an integrated portfolio of products providing clinical researchers with the most advanced tools available to study haematological disorders, including CytoCell® fluorescence in-situ hybridisation (FISH) probes and myProbes® custom FISH probes, SureSeq™ next generation sequencing (NGS) panels and myPanel™ custom panels, and CytoSure® array products and custom arrays.

Our products are backed by deep technical expertise and dedicated customer support.


Featured products

Featured FISH probes

CytoCell CKS1B/CDKN2C (P18) Amplification/ Deletion Image

CytoCell CKS1B/CDKN2C (P18) Amplification/ Deletion

The CKS1B/CDKN2C product consists of a 182kb probe, labelled in red, covering the entire CKS1B gene and flanking regions, including the PYGO2 and ZBTB7B genes, and a green probe covering a 170kb region, including the entire CDKN2C gene, the D1S1661 marker and the centromeric end of the FAF1 gene.

View Product
CytoCell P53 (TP53) Deletion Image

CytoCell P53 (TP53) Deletion

The P53 probe mix consists of a 161kb probe, labelled in red that covers the whole P53 (TP53) gene and the flanking regions. The probe mix also contains a control probe for the 17 centromere (D17Z1) that is labelled in green.

View Product

Featured NGS panels

SureSeq Pan-Myeloid Panel Image

SureSeq Pan-Myeloid Panel

The SureSeq Pan-Myeloid Panel accurately detects SNVs and indels in genes such as CEBPA, JAK2, CALR and MPL, as well as structural variants including FLT3-ITDs and KMT2A-PTDs, providing researchers with a single NGS workflow delivering a comprehensive picture of the genetic make-up of each myeloid sample. The figure (above) shows FLT3-ITDs of various sizes and even regions containing multiple ITDs can be confidently detected. ITD sizes are [A] 174 bp, [B] 225 bp, [C] 195 bp with additional 6 bp, [D] 120 bp and [E] 168 bp with additional 69 bp.

View Product
SureSeq CLL + CNV Panel Image

SureSeq CLL + CNV Panel

The SureSeq CLL + CNV Panel has been designed in collaboration with recognised cancer experts to detect 13 key genes and 5 chromosomal regions implicated in CLL progression. The figure (above) compares SureSeq CLL + CNV Panel data with array data for a 42.7Mb deletion of 11q covering ATM (top) and a 0.6Mb biallelic loss called within a larger ~1Mb single allele deletion in the region covering DLEU2/DLEU1/DLEU7 on chromosome 13q (bottom).

View Product
View all products

Featured haematological cancer resources

All resources & support

Have a question or want to know more about our haematological cancer products?

Call +44 (0)1865 856800 Email Send us a message and we will get back to you